The global epigenetic antibodies market size is calculated at USD 2.70 billion in 2025 and is expected to reach around USD 12.01 billion by 2034, growing at a CAGR of 18.04% for the forecasted period.
New research has uncovered a mechanism for parents to pass down longevity, to their progeny, via changes to their lysosome metabolism.